We are live on ! Find out more
GMAB icon

Genmab
GMAB

223 hedge funds and large institutions have $1.28B invested in Genmab in 2024 Q3 according to their latest regulatory filings, with 29 funds opening new positions, 98 increasing their positions, 66 reducing their positions, and 24 closing their positions.

New
Increased
Maintained
Reduced
Closed

48% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 66

21% more first-time investments, than exits

New positions opened: 29 | Existing positions closed: 24

5.35% more ownership

Funds ownership: 73.7% → 79.04% (+5.3%)

2% more funds holding

Funds holding: 219 → 223 (+4)

4% more capital invested

Capital invested by funds: $1.23B → $1.28B (+$51.5M)

59% less call options, than puts

Call options by funds: $256K | Put options by funds: $626K

Holders
223
Holders Change
+4
Holders Change %
+1.83%
% of All Funds
3.2%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
98
Reduced
66
Closed
24
Calls
$256K
Puts
$626K
Net Calls
-$370K
Net Calls Change
+$148K

Top Buyers

Rank Fund Capital Flow
1
OAG
Orbis Allan Gray
Bermuda
+$44.8M
2
Morgan Stanley
Morgan Stanley
New York
+$16.3M
3
Renaissance Technologies
Renaissance Technologies
New York
+$8.66M
4
HL
Harding Loevner
New Jersey
+$8M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$7.51M

Top Sellers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
-$12.4M
2
CSS
Cubist Systematic Strategies
Connecticut
-$7M
3
Marshall Wace
Marshall Wace
United Kingdom
-$5.89M
4
AllianceBernstein
AllianceBernstein
Tennessee
-$2.72M
5
American Century Companies
American Century Companies
Missouri
-$1.47M
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
26
Fidelity Investments
Massachusetts
$6.78M +$884K +33,076 +13%
Hudson Bay Capital Management
27
Hudson Bay Capital Management
Connecticut
$6.46M – – –
OAM
28
Oppenheimer Asset Management
New York
$5.66M +$379K +14,165 +6%
HJGA
29
Hardman Johnston Global Advisors
Connecticut
$5.56M -$167K -6,263 -3%
ISL
30
Ingalls & Snyder LLC
New York
$5.33M -$300K -11,217 -5%
Balyasny Asset Management
31
Balyasny Asset Management
Illinois
$5.18M +$5.69M +212,663 New
Natixis Advisors
32
Natixis Advisors
Massachusetts
$5.04M +$1.27M +47,437 +30%
LPL Financial
33
LPL Financial
California
$4.61M +$1.15M +43,118 +30%
US Bancorp
34
US Bancorp
Minnesota
$4.19M +$634K +23,723 +16%
F
35
Folketrygdfondet
Norway
$4.15M – – –
RJA
36
Raymond James & Associates
Florida
$4.14M +$96.2K +3,598 +2%
Stifel Financial
37
Stifel Financial
Missouri
$4.12M -$159K -5,936 -3%
NW
38
NewEdge Wealth
Pennsylvania
$2.94M +$222K +8,294 +7%
TCM
39
Tang Capital Management
California
$2.44M – – –
PNC Financial Services Group
40
PNC Financial Services Group
Pennsylvania
$2.27M -$128K -4,774 -5%
GAM
41
Groupama Asset Management
France
$2.19M +$32.8K +1,225 +12%
AssetMark Inc
42
AssetMark Inc
California
$2.01M +$308K +11,519 +16%
Bank of Montreal
43
Bank of Montreal
Ontario, Canada
$1.84M -$31.2K -1,168 -2%
MML Investors Services
44
MML Investors Services
Massachusetts
$1.79M +$101K +3,785 +5%
BAMCO Inc
45
BAMCO Inc
New York
$1.76M -$395K -14,779 -17%
Dimensional Fund Advisors
46
Dimensional Fund Advisors
Texas
$1.72M -$389K -14,543 -17%
Bank of New York Mellon
47
Bank of New York Mellon
New York
$1.68M -$34.7K -1,297 -2%
MAM
48
Madison Asset Management
Wisconsin
$1.65M +$244K +9,114 +16%
WJWM
49
Williams Jones Wealth Management
New York
$1.65M -$428K -16,014 -19%
TI
50
Trexquant Investment
Connecticut
$1.56M +$1.4M +52,334 +455%
1
2
3 4 5

GMAB Hedge Fund Activity: Q3 2024 in Review

223 of the 6,964 institutional investors tracked by Wall St. Rank reported a position in Genmab (GMAB) for Q3 2024, worth a combined $1.28B — up 4.2% from $1.23B a quarter earlier.

Buyers outnumbered sellers: 29 funds opened new GMAB positions and 24 closed out — a net gain of 5 holders — while 98 added to existing stakes and 66 trimmed.

The largest buyer was Orbis Allan Gray, opening a new position worth an estimated $44.8M. The largest seller was BlackRock, cutting an estimated $12.4M.

  • 223 institutional investors held Genmab (GMAB) as of Q3 2024, up from 219 in Q2 2024.
  • Funds reported $1.28B of Genmab stock for Q3 2024, up 4.2% quarter-over-quarter.
  • 29 funds opened new Genmab positions in Q3 2024 and 24 closed out, a net change of +5 holders.
  • The largest Genmab buyer in Q3 2024 was Orbis Allan Gray, an estimated $44.8M added.
  • The largest Genmab seller in Q3 2024 was BlackRock, an estimated $12.4M sold.

Based on aggregated 13F filings for Q3 2024.